1-7 of 7
Keywords: octreotide
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (1998) 94 (6): 609–614.
Published: 01 June 1998
... the endogenous insulin response was inhibited with subcutaneous octreotide. 3. After placebo, hypertensive patients had slightly but significantly higher blood glucose levels than controls ( P < 0.0001), but comparable insulin concentrations ( P > 0.5). Plasma noradrenaline levels were consistently lower...
Clin Sci (Lond) (1996) 91 (5): 601–606.
Published: 01 November 1996
...Yi-Tsau Huang; Ju-Fen Tsai; Tsun-Bin Liu; Chuang-Ye Hong; May C.-M. Yang; Han-Chieh Lin 1. It has been reported that octreotide partially corrects the hyperdynamic state in patients and animals with portal hypertension. The aim of the present study was to investigate whether chronic administration...
Clin Sci (Lond) (1993) 84 (2): 193–199.
Published: 01 February 1993
... with the somatostatin analogue octreotide (0.8 μg/kg subcutaneously) given 30 min before the insulin infusion. 4. The nadir in blood glucose concentration at the hypoglycaemic reaction was similar in both groups and glucose recovery was complete by 60 min after the hypoglycaemic reaction. Plasma catecholamine...
Clin Sci (Lond) (1992) 83 (5): 575–581.
Published: 01 November 1992
...Martin Muntzel; Thierry Hannedouche; Roberte Niesor; Laure-Helène Nöel; Jean-Claude Souberbielle; Bernard Lacour; Tilman Drüeke 1. To determine whether treatment with octreotide, a somatostatin analogue, may diminish or prevent long-term diabetic renal hypertrophy and nephropathy, uninephrectomized...